Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment - Drugs.com MedNews
Links shared publicly online about this topic.
- 372total visits
Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment - Drugs.com MedNews
New class of dual action long-acting Muscarinic Antagonist Beta-2 Agonist (MABA) has potential to change the paradigm of COPD treatment Almirall is aiming at st
View full resource at drugs.com
Tags: COPD, Disease and Condition, Drug, Pulmonology, disease
Most Recently Shared on April 11, 2011 at 7:08 pm By:
Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Dise... http://bit.ly/epp6MS #drug
Advertisement
